The global hidradenitis suppurativa (HS) treatment market is set to surpass a remarkable valuation of USD 763.6 million in 2023, and projections indicate this figure will rise to USD 1,240.9 million by 2033, registering a steady CAGR of 4.97% during the forecast period. Pipeline Therapies Driving Market Growth: The HS treatment market is witnessing significant …